Moderna and Pfizer Begin Late-Stage Vaccine Trials

The New York Times | July 27, 2020, 6:33 a.m. | Original
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective.
‘We Are Not Prisoners of the Pandemic,’ W.H.O. Leader says Your Tuesday Briefing